Preferences and attitudes to illicit drug policy held by individuals are likely to be an important influence in the development of illicit drug policy. Among the key factors impacting on an individual's preferences over substance use policy are their beliefs about the costs and benefits of drug...

This paper investigates whether cannabis use leads to worse mental health. To do so, we account for common unobserved factors affecting mental health and cannabis consumption by modeling mental health jointly with the dynamics of cannabis use. Our main finding is that using cannabis increases...

Cannabis is no longer a movement. It is an industry estimated to be worth $50 billion as of January 2019. Currently, 46 states in the United States (the “U.S.”) have laws permitting or decriminalizing marijuana or marijuana-based products. Many of these states are enacting these marijuana...

Although many states have decriminalized or legalized cannabis, it remains a Schedule 1 drug under the federal Controlled Substances Act. The conflict between federal and state law presents many complicated issues, including significant problems relating to insurance coverage. Insurance law...

In a healthcare landscape that routinely ignores women’s pain, many women turn to cannabis to manage their otherwise debilitating chronic pelvic pain caused by conditions such as endometriosis and polycystic ovary syndrome. This paper explores how the Controlled Substances Act wrongly...